BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34153489)

  • 21. General anesthesia is associated with reduced early failure among patients undergoing hemodialysis access.
    Beaulieu RJ; Locham S; Nejim B; Dakour-Aridi H; Woo K; Malas MB
    J Vasc Surg; 2019 Mar; 69(3):890-897.e5. PubMed ID: 30798844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular access for hemodialysis in the elderly.
    Arhuidese IJ; Cooper MA; Rizwan M; Nejim B; Malas MB
    J Vasc Surg; 2019 Feb; 69(2):517-525.e1. PubMed ID: 30683199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD.
    Shechter SM; Chandler T; Skandari MR; Zalunardo N
    Am J Kidney Dis; 2017 Sep; 70(3):368-376. PubMed ID: 28599902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with lower extremity dialysis access have poor primary patency and survival.
    Pike SL; Farber A; Arinze N; Levin S; Cheng TW; Jones DW; Tan TW; Malas M; Rybin D; Siracuse JJ
    J Vasc Surg; 2019 Dec; 70(6):1913-1918. PubMed ID: 31147128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of preoperative vein mapping with hemodialysis access characteristics and outcomes in the Vascular Quality Initiative.
    Fedorova E; Zhang GQ; Shireman PK; Woo K; Hicks CW
    J Vasc Surg; 2022 Apr; 75(4):1395-1402.e5. PubMed ID: 34718099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arteriovenous Vascular Access-Related Procedural Burden Among Incident Hemodialysis Patients in the United States.
    Woodside KJ; Repeck KJ; Mukhopadhyay P; Schaubel DE; Shahinian VB; Saran R; Pisoni RL
    Am J Kidney Dis; 2021 Sep; 78(3):369-379.e1. PubMed ID: 33857533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative Opioid and Nonopioid Prescribing Patterns in AVF/AVG Creation.
    Phair J; Choinski K; Carnevale M; DeRuiter B; Scher L; Lipsitz E; Koleilat I
    Ann Vasc Surg; 2021 Apr; 72():290-298. PubMed ID: 32949735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes.
    Allon M; Al-Balas A; Young CJ; Cutter GR; Lee T
    J Am Soc Nephrol; 2023 Sep; 34(9):1589-1600. PubMed ID: 37401775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs.
    Arnold RJG; Han Y; Balakrishnan R; Layton A; Lok CE; Glickman M; Rajan DK
    J Vasc Interv Radiol; 2018 Nov; 29(11):1558-1566.e2. PubMed ID: 30293731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of age, diabetes, gender, and access type on costs associated with vascular access among Chinese patients on hemodialysis.
    Xiong Y; Yu Y; Yang Y; Wang L; Shi P; Deng Y; Li Y; Fu P
    Int J Artif Organs; 2021 May; 44(5):302-309. PubMed ID: 33016167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodialysis Access in the Elderly: Outcomes among Patients Older than Seventy.
    Jadlowiec CC; Mannion EM; Lavallee M; Brown MG
    Ann Vasc Surg; 2016 Feb; 31():77-84. PubMed ID: 26616499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.
    Mohr BA; Sheen AL; Roy-Chaudhury P; Schultz SR; Aruny JE;
    J Vasc Interv Radiol; 2019 Feb; 30(2):203-211.e4. PubMed ID: 30717951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriovenous Access Type and Risk of Mortality, Hospitalization, and Sepsis Among Elderly Hemodialysis Patients: A Target Trial Emulation Approach.
    Lyu B; Chan MR; Yevzlin AS; Gardezi A; Astor BC
    Am J Kidney Dis; 2022 Jan; 79(1):69-78. PubMed ID: 34118301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health status as a potential mediator of the association between hemodialysis vascular access and mortality.
    Grubbs V; Wasse H; Vittinghoff E; Grimes BA; Johansen KL
    Nephrol Dial Transplant; 2014 Apr; 29(4):892-8. PubMed ID: 24235075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.
    Rosas SE; Feldman HI
    Ann Surg; 2012 Jan; 255(1):181-6. PubMed ID: 21918428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical and Economic Effect of Vascular Access Selection in Patients Initiating Hemodialysis with a Catheter.
    Al-Balas A; Lee T; Young CJ; Kepes JA; Barker-Finkel J; Allon M
    J Am Soc Nephrol; 2017 Dec; 28(12):3679-3687. PubMed ID: 28710090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation.
    Solid CA; Carlin C
    Am J Nephrol; 2012; 35(6):498-508. PubMed ID: 22584153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic impact of the beneficial effect of changing vascular anastomotic technique in hemodialysis access.
    Shenoy S; Woodward RS
    Vasc Endovascular Surg; 2005; 39(5):437-43. PubMed ID: 16193217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population.
    Leake AE; Yuo TH; Wu T; Fish L; Dillavou ED; Chaer RA; Leers SA; Makaroun MS
    J Vasc Surg; 2015 Jul; 62(1):123-7. PubMed ID: 25769391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endovascular versus surgical creation of arteriovenous fistula in hemodialysis patients: Cost-effectiveness and budget impact analyses.
    Rognoni C; Tozzi M; Tarricone R
    J Vasc Access; 2021 Jan; 22(1):48-57. PubMed ID: 32425096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.